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Evelyn Teran, Aron D. Branscomb¤, Joni M. Seeling*
Department of Biology, City University of New York, Queens College, Flushing, New York, United States of America

Abstract
The Wnt pathway is a key regulator of development and tumorigenesis. Dpr (Dact/Frodo) influences Wnt signaling in part
through the interaction of its PDZ-B domain with Dsh’s PDZ domain. Studies have shown that XDpr1a and its close relative,
Frodo, are involved in multiple steps of the Wnt pathway in either inhibitory or activating roles. We found that XDpr1a is
phosphorylated by casein kinase Id/e (CKId/e), an activator of Wnt signaling, in the presence of XDsh. Abrogating XDpr1a’s
ability to bind XDsh through mutation of XDpr1a’s PDZ-B domain blocks CK1d/e’s phosphorylation of XDpr1a. Conversely,
XDsh possessing a mutation in its PDZ domain that is unable to bind XDpr1a does not promote XDpr1a phosphorylation.
Phosphorylation of XDpr1a and XDsh by CKId/e decreases their interaction. Moreover, the phosphorylation of XDpr1a by
CKId/e not only abrogates XDpr1a’s promotion of b-catenin degradation but blocks b-catenin degradation. Our data
suggest that XDpr1a phosphorylation by CKId/e is dependent on the interaction of XDpr1a’s PDZ-B domain with XDsh’s PDZ
domain, and that the phosphorylation state of XDpr1a determines whether it inhibits or activates Wnt signaling.
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Dsh’s DIX and PDZ domains are likely to function in canonical
Wnt signaling, while its PDZ and DEP domains are likely to
function in noncanonical Wnt signaling [15–17]. Dsh is thought to
act as a molecular scaffold in signal transduction processes, since at
least eighteen binding partners of Dsh have been identified [14].
PDZ domains are protein–protein interaction domains and
therefore are important for the scaffolding function of Dsh.
Xenopus Dapper1a (XDpr1a) and the highly related protein
Functional regulator of disheveled in ontogenesis (Frodo), are
novel mediators of Wnt signaling which were isolated in
independent yeast two-hybrid screens for proteins that interact
with Xenopus Dsh (XDsh) [18,19]. XDpr1a and Frodo have two
defined motifs: an N-terminal leucine zipper (LZ) domain, and a
C-terminal PDZ-binding (PDZ-B) domain [18,19]. The LZ
domain is unnecessary for XDpr1a’s interaction with XDsh, since
deletion of the LZ domain does not influence XDpr1a’s ability to
associate with XDsh, although it does affect the ability of XDpr1a
to inhibit Wnt signaling [18]. However, deletion or mutation of
the PDZ-B domain impedes XDpr1a or Frodo from associating
with XDsh [18,19]. Recently, a domain was identified in the
central region of human Dpr1 that also mediates Dvl binding, but
the role of this region in XDpr1a is not known [20].
XDpr1a and Frodo are the result of a recent gene duplication in
Xenopus and intriguingly, studies have shown that XDpr1a and
Frodo are involved in multiple steps of the Wnt pathway in either
inhibitory or activating roles [21,22]. In many instances, XDpr1a
and/or Frodo negatively regulate Wnt signaling. XDpr1a forms a

Introduction
In canonical Wnt signaling, Wnt activates b-catenin-dependent
transcription via a phosphorylation-regulated signal transduction
cascade. In the absence of Wnt, the cytoplasmic b-catenin
degradation complex, whose core components include b-catenin,
adenomatous polyposis coli (APC), axin, and glycogen synthase
kinase 3b (GSK3b), is stable and casein kinase Ia (CKIa) primes bcatenin by phosphorylating Ser45, which is required for GSK3b to
phosphorylate three upstream Ser/Thr residues [1]. Phosphorylated b-catenin is then ubiquitinated and degraded by the proteasome.
When Wnt binds to low density lipoprotein receptor-related protein
5/6 (LRP5/6) and frizzled (fz) coreceptors, an intracellular signaling
cascade is activated that includes axin binding to LRP5/6, and
disheveled (Dsh/Dvl) binding to fz, bringing b-catenin and APC to
the membrane as well [2–6]. CKIe positively regulates Wnt
signaling, potentially by phosphorylating Dsh, and LRP5/6 is
phosphorylated by GSK3b and CKI [7–9]. These events inactivate
the b-catenin degradation complex, reduce b-catenin phosphorylation, and increase b-catenin abundance. b-catenin then forms a
complex with a Lef/Tcf transcription factor, activating transcription of dorsalizing factors in early Xenopus development and cell
cycle regulators in mammalian cells [10–12].
Dsh has three highly conserved domains: an N-terminal DIX
domain (which is also present in axin), a central PDZ domain (first
identified in PSD, Discs large, and ZO1), and a C-terminal DEP
domain (first identified in Dsh, Egl-10, and Pleckstrin) [13,14].
PLoS ONE | www.plosone.org
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complex with XDsh, axin, GSK3b, CKIe, and b-catenin;
exogenous XDpr1a increases axin and GSK3b, and reduces
CKIe, in this complex, resulting in reduced b-catenin abundance
and reduced activation of Wnt responsive genes [18]. Furthermore, Dpr inhibits Wnt signaling both from the cytoplasm and the
nucleus. Mammalian Dpr1/Dact inhibits expression of Wntresponsive reporters through its promotion of Dvl degradation in a
lysosome-dependent pathway, and by inhibiting the binding of
LEF1 with b-catenin, but promoting the binding of LEF1 with a
corepressor, histone deacetylase 1 (HDAC1) [20,23].
In contrast, XDpr1a and/or Frodo also activate Wnt signaling.
Reducing Frodo abundance with antisense morpholino oligonucleotides (MOs) inhibits Xwnt8- and XDsh-induced body axes and
reduces Wnt-dependent reporter activity in Xenopus [18,19]. In
addition, Dpr1 enhances Wnt8’s ventralization and posteriorization
activities in zebrafish [21,22]. Using a similar experimental system,
however, Frodo and XDpr1a were found to either inhibit or activate
Wnt signaling, dependent on the point at which the pathway was
activated [22]. Frodo and XDpr1a MOs reduce b-cateninindependent transcription induced by TCF-VP16, suggesting that
Frodo and XDpr1a are required for Tcf-mediated transcription, and
Frodo and XDpr1a MOs increase Xwnt8-induced siamois reporter
activity, suggesting that Frodo and XDpr1a inhibit Wnt signaling.
The molecular mechanisms underlying these apparent differences in
function have not yet been explored.
Phosphorylation plays a key role in the regulation of Wnt
signaling, and CKI family members appear to have several targets
in the Wnt pathway. CKIa phosphorylates b-catenin to negatively
regulate the pathway [24]. CKId and CKIe are two highly related
CKI isoforms likely to have similar functions, since their kinase
domains are 98% identical and they have 53% identical C-terminal
tails, unique to CKId and CKIe, that inhibit their function when
autophosphorylated. CKId and CKIe activate Wnt signaling
through their putative targets of Dsh and/or Lef/Tcf, while CKIc
activates Wnt signaling through LRP5/6 phosphorylation [24]. We
have shown that CKId and CKIe both interact directly with Dvl-1,
suggesting that they influence Wnt signaling using a common
mechanism [8]. CKId directly phosphorylates numerous components of the b-catenin degradation complex in vitro, i.e., Dsh, APC,
axin, and b-catenin, and CKIe phosphorylates axin and b-catenin in
vivo [8]. In addition, we found that CKIe dissociates protein
phosphatase 2A (PP2A) A and C subunits from the b-catenin
degradation complex both in vitro and in vivo, and that CKId and
CKIe both act upstream of the B56a regulatory subunit of PP2A in
Xenopus body axis formation, which is a Wnt-dependent process [8].
The circumstances that determine whether Dpr inhibits or
activates Wnt signaling are not known. An appealing hypothesis is
that posttranslational modifications of Dpr may regulate its role in
Wnt signaling. Since phosphorylation is a common mechanism to
alter a protein’s activity, we analyzed the phosphorylation of Dpr
and found that XDpr1a is phosphorylated by CKId/e in the
presence of XDsh. CKId’s phosphorylation of XDpr1a reduces its
interaction with XDsh and transforms XDpr1a from a promoter
to an inhibitor of b-catenin degradation. Our data suggest that
XDpr1a inhibits Wnt signaling when unphosphorylated and
bound to XDsh, but activates Wnt signaling when phosphorylated
by CKId/e and associated with other Wnt players.

vitro, GSK3b and CKId/e. We found that CKId, but not GSK3b,
was able to phosphorylate XDpr1a, as exemplified by a gel shift
(Fig. 1A, compare lane 2 with lane 1, and data not shown).
XDpr1a was initially isolated because of its interaction with XDsh,
and XDsh is phosphorylated by CKId/e in vitro [8,18,19], so we
determined if XDsh influences the phosphorylation state of
XDpr1a. We found that XDsh induced an upward mobility shift
of XDpr1a similar to the shift seen in the presence of CKId
(Fig. 1A, compare lane 3 with lane 1). Note that XDpr1a migrates
slower than its calculated molecular weight of 91 kD, likely due to
as yet uncharacterized posttranslational modifications. Intriguingly, the presence of both CKId and XDsh resulted in a hypershift of
XDpr1a (Fig. 1A, compare lane 4 with lanes 1–3), suggesting that
XDsh promotes the phosphorylation of XDpr1a by CKId. This
also suggests that the modest gel shift seen in the presence of CKId
alone (Fig. 1A, lane 2) was due to limiting amounts of endogenous
Dsh in reticulocyte lysates, whereas the modest gel shift in the
presence of XDsh alone (Fig. 1A, lane 3) was due to limiting
amounts of endogenous CKId in reticulocyte lysates, and that the
supershift in the presence of XDsh and CKId (Fig. 1A, lane 4)
occurs when neither XDsh nor CKId are limiting. As reported
previously [8,18,19], we found that CKId also phosphorylates
XDsh (Fig. 1, compare lane 4 with lane 3). The broad XDsh band
in the absence of CKId (Fig. 1A, lane 3) suggests that endogenous
CKId and/or other kinases in the reticulocyte lysate phosphorylate XDsh.

Figure 1. XDsh promotes a CKId-mediated mobility shift of
XDpr1a. A. XDpr1a exhibits a mobility shift in the presence of CKId
and XDsh. In vitro transcribed and translated XDpr1a exhibits a mobility
shift in the presence of purified CKId, and in the presence of in vitro
transcribed and translated XDsh. The mobility shift is greater in the
presence of both CKId and XDsh. XDsh also exhibits a mobility shift in
the presence of CKId. The XDpr1a mobility shift present in lanes 2 and 3
is likely due to limiting amounts of endogenous XDsh and CKId in the
reticulocyte lysates used in the in vitro transcription and translation,
respectively. B. XDsh-mediated CKId phosphorylation of XDpr1a has
little effect on XDpr1a abundance. Phosphorylation reactions were
carried out as in A., but with the inclusion of luciferase as a loading
control. XDpr1a and luciferase bands were quantitated, and the XDpr1a
signal was normalized to that of luciferase. The luciferase-normalized
signals were then normalized to that of XDpr1a alone. Error bars signify
standard deviation (n = 3 trials).
doi:10.1371/journal.pone.0005522.g001

Results
XDsh promotes a CKId-induced phosphorylation of
XDpr1a
To study the phosphorylation of XDpr1a, we first examined the
ability of two Wnt pathway kinases to phosphorylate XDpr1a in
PLoS ONE | www.plosone.org
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Because mobility shifts of phosphorylated proteins can cause the
broadening of SDS-PAGE bands and make it difficult to estimate
protein abundance determinations by eye, we quantitated the
XDpr1a signal from CKId phosphorylation reactions to determine
if CKId-mediated phosphorylation of XDpr1a affects XDpr1a
abundance. We found that the abundance of XDpr1a is relatively
constant in the presence of XDsh and/or CKId (Fig. 1B). This
suggests that while CKId phosphorylates XDpr1a, it has little
effect on XDpr1a abundance. To verify that the XDsh/CKIdmediated XDpr1a gel shift was due to phosphorylation, we carried
out CKId phosphorylation reactions in the presence of
[c-33P]ATP. The presence of XDsh and CKId induced incorporation of [c-33P]ATP into XDpr1a (Fig. 2A, compare lane 4 to 3),
which indicates XDpr1a is phosphorylated under these conditions,
and induced a gel-shift that comigrates with the [35S]methioninelabeled XDpr1a gel-shift (Fig. 2A, compare lane 4 to 3 and lane 2
to 1), showing that the gel-shifted XDpr1a is phosphorylated. The
gel-shift of XDpr1a represents a 4.060.7% increase in molecular
weight, or approximately 6 kD. The data confirm that the XDsh/
CKId-mediated gel-shift of XDpr1a is due to XDpr1a phosphorylation. In summary, XDsh promotes the phosphorylation of
XDpr1a by CKId, perhaps by bridging XDpr1a to CKId.

Figure 2. XDsh promotes the phosphorylation of XDpr1a by
CKId both in vitro and in vivo. A. XDsh induces a CKId-mediated
phosphorylation of XDpr1a in vitro. Phosphorylation reactions were
carried out in the presence of [35S]methionine-XDpr1a (lanes 1 and 2) or
[c-33P]ATP (lanes 3 and 4) and in the absence (lanes 1 and 3) or
presence (lanes 2 and 4) of XDsh and CKId. Lanes 3 and 4 contain the
immunopellet from an anti-Myc immunoprecipiation of [c-33P]ATPlabeled Myc:XDpr1a. XDpr1a undergoes a gel-shift and shows increased
incorporation of [c-33P]ATP in the presence of XDsh and CKId. B. CKIe
phosphorylates XDpr1a in vivo. HEK293 cells transfected with Flag:XDpr1a alone or with CKIe and XDsh were metabolically labeled with
[32P]orthophosphoric acid prior to XDpr1a immunoprecipitation with
anti-Flag antibodies. The cotransfection of CKIe and XDsh with XDpr1a
induces a gel-shift and increases [32P]orthophosphoric acid incorporation into XDpr1a. This result is representative of experiments repeated
three times with similar results.
doi:10.1371/journal.pone.0005522.g002

CKIe phosphorylates XDpr1a in vivo
To examine the phosphorylation of XDpr1a by CKId/e under
more physiological conditions, we monitored the effects of
modulating CKId/e activity on XDpr1a phosphorylation in vivo.
HEK293 cells were transfected with Myc:XDpr1a alone or with
HA:XDsh and CKIe, and metabolically labeled with [32P]orthophosphoric acid. CKIe induced an XDpr1a gel-shift and
promoted increased incorporation of [32P]orthophosphoric acid
into XDpr1a (Fig. 2B). The gel-shift of XDpr1a represents a
9.160.8% increase in molecular weight, or approximately 13 kD,
somewhat higher than the in vitro shift of 6 kD, suggesting that
XDpr1a phosphorylation is more robust in vivo. This result extends
our in vitro data and shows that XDpr1a is phosphorylated by
CKIe in vivo.

phosphorylation of XDpr1a. We found that XDpr1aMNTV,
containing a T822N point mutation in its PDZ-B domain,
behaved similarly to XDpr1aDMTTV, and did not exhibit a
mobility shift (Fig. 3A, compare lane 8 with lane 7). These data
suggest that an intact PDZ-B domain in XDpr1a is required for
XDsh-dependent phosphorylation of XDpr1a by CKId.

Mutation of the XDsh PDZ-B binding domain blocks
XDpr1a phosphorylation

PDZ-B mutants of XDpr1a are not phosphorylated by
CKId

To further show the importance of XDsh in the phosphorylation of XDprIa by CKId, we examined whether a mutation in
XDsh that reduces its interaction with XDpr1a’s PDZ-B domain
still promotes the phosphorylation of XDpr1a by CKId. The
region of XDsh’s PDZ domain that binds to XDpr1a’s PDZ-B was
identified by X-ray crystallography [18]. An N317T point
mutation in XDsh’s PDZ-B binding domain (*aXDsh) diminishes
its interaction with XDpr1a, whereas a triple mutation in a PDZ
domain loop upstream of XDsh’s PDZ-B binding domain
(272QSNE275 to 272AANA275, ***b-bXDsh) does not [18].
We examined the ability of *aXDsh and ***b-bXDsh to promote
the phosphorylation of XDpr1a by CKId. XDpr1a exhibited a
mobility shift indicative of hyperphosphorylation in the presence of
XDsh and ***b-bXDsh (Fig. 3B, compare lanes 2 and 3 to lane 1),
whereas XDpr1a did not exhibit a mobility shift in the presence of
*aXDsh (Fig. 3B, lane 4 compared to lane 1). The inability of an
XDsh protein containing a point mutation in its PDZ-B binding
domain to promote the phosphorylation of XDpr1a by CKId
suggests that XDsh must retain its ability to bind XDpr1a in order
to promote XDpr1a phosphorylation.

Mutational analyses have shown that the PDZ-B domain of
XDpr1a/Frodo interacts with the PDZ domain of XDsh [18,19].
If XDsh is required to promote the phosphorylation of XDpr1a by
CKId, then mutants of XDpr1a with reduced XDsh binding may
not be phosphorylated by CKId. We tested this hypothesis by
determining if mutation or deletion of the XDpr1a PDZ-B domain
abrogated the ability of XDsh to promote CKId-mediated
XDpr1a phosphorylation. We used in vitro transcription/translation to synthesize wild-type and mutant XDpr1a proteins, as well
as XDsh, followed by a phosphorylation reaction in the presence
of purified CKId. We tested three XDpr1a mutants, one that
binds XDsh’s PDZ domain (XDpr1aDLZ), and two that do not
(XDpr1aDMTTV and XDpr1aMNTV) [18]. The XDpr1aDLZ
protein, lacking the N-terminal 129 amino acids including the
leucine zipper motif, served as a control and behaved similarly to
wild-type XDpr1a, undergoing a gel shift indicative of hyperphosphorylation in the presence of CKId (Fig. 3A, compare lane 2
with lane 1, and lane 4 with lane 3). XDpr1aDMTTV lacks the
PDZ-B domain and did not undergo a mobility shift in the
presence of CKId, suggesting that it is not phosphorylated by
CKId (Fig. 3A, compare lane 6 with lane 5). Since deletion of the
XDpr1a PDZ-B domain inhibited XDsh’s promotion of XDpr1a
phosphorylation by CKId, we examined whether a point mutation
within the PDZ-B motif would affect XDsh-dependent CKId
PLoS ONE | www.plosone.org

CKId reduces the interaction between XDpr1a and XDsh
CKId/e destabilizes the b-catenin degradation complex [8],
and Dpr and Dsh are both components of this complex, so CKId
may disrupt the interaction between Dpr and Dsh as well. We
tested this hypothesis using an in vitro coimmunoprecipitation
3
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Figure 4. Phosphorylation of XDpr1a and XDsh by CKId
reduces their interaction. A. Myc-tagged XDpr1a was immunoprecipitated in the presence of HA-tagged XDsh in the absence or
presence of CKId. The presence of CKId reduced the coimmunoprecipitation of XDsh with XDpr1a. B. Quantitation of the relative
coimmunoprecipitation (coIP) of XDsh with XDpr. The quantitation of
the coimmunoprecipitation of XDsh with XDpr1a revealed that the
presence of CKId reduced the interaction between XDpr1a and XDsh by
approximately one-half when compared to the control. Error bars
signify standard deviation.
doi:10.1371/journal.pone.0005522.g004

Figure 3. Mutations of XDpr1a or XDsh that block their mutual
interaction also block CKId-mediated XDpr1 phosphorylation.
A. Deletion or mutation of XDpr1a’s PDZ-B domain blocks CKIdmediated XDpr1a phosphorylation. Deletion of the leucine zipper
domain of XDpr1a (DLZ), which does not affect its ability to bind XDsh,
does not affect the ability of XDpr1a to be phosphorylated by CKId, as
exhibited by a mobility shift. XDpr1a containing a deletion (DMTTV) or a
point mutation (MNTV) of its PDZ-B domain is not phosphorylated by
CKId. The braces in lanes 2 and 4 bracket phosphorylated XDpr1a and
DLZ, respectively. B. An Asn317Thr Mutation in XDsh’s PDZ domain
abrogates its promotion of XDpr1a phosphorylation. ***b-bXDsh, which
contains Gln272Ala, Ser273Ala, and Glu275Ala mutations in a PDZ
domain loop outside of the PDZ-B binding domain, promotes XDpr1a
phosphorylation by CKId at a level similar to that of wild-type XDsh,
while *aXDsh, which contains an Asn317Thr mutation in the PDZ-B
binding domain within its PDZ domain, does not.
doi:10.1371/journal.pone.0005522.g003

immunosupernatant (Fig. 4A, compare lanes 4 and 3). Because of
the CKId-induced mobility shift of XDsh, determination of the
extent of the reduction of XDsh coimmunoprecipitation in the
presence of CKId is difficult to make by eye, therefore we
quantitated the coimmunoprecipitatipon of XDsh. We found that
CKId reduced the coimmunoprecipitation of XDsh by XDpr1a by
approximately one-half (Fig. 4B). This suggests that XDpr1a and
XDsh interact transiently, dissociating soon after XDpr1a and/or
XDsh is phosphorylated by CKId. Therefore, CKId reduces the
interaction between XDsh and XDpr1a and is likely to play a
significant role in Wnt signaling activation.

assay. We immunoprecipitated Myc-tagged XDpr1a from a
reaction containing HA-tagged XDsh in the absence or presence
of CKId. The presence of CKId dramatically decreased the
immunoprecipitation of XDsh with XDpr1a (Fig. 4A, compare
lanes 2 and 1), resulting in a concomitant increase of XDsh in the
PLoS ONE | www.plosone.org
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XDpr1a promotes b-catenin degradation in the absence
of CKId, but inhibits b-catenin degradation in its presence
XDpr1a has been shown to reduce b-catenin abundance both
in Xenopus embryos and in mammalian tissue culture [18]. To
investigate the functional consequences of XDsh-mediated CKId
phosphorylation of XDpr1a, we utilized an in vitro b-catenin
degradation assay using Xenopus egg extracts [8,25,26]. When
unmodified XDpr1a was added to Xenopus egg extracts, the rate of
b-catenin degradation increased, reducing the half-life of b-catenin
approximately two-fold, from 1.8 to 0.9 hours, indicating an
inhibition of canonical Wnt signaling (Fig. 5). However, when
XDpr1a was preincubated with CKId, b-catenin degradation was
blocked, indicative of Wnt pathway activation (Fig. 5). These data
suggest that XDpr1a acts as a molecular switch, inhibiting Wnt
signaling when unphosphorylated, but promoting Wnt signaling
when phosphorylated by CKId.
Figure 5. Unphosphorylated XDpr1a promotes, but CKIdphosphorylated XDpr1a blocks, b-catenin degradation. Myc:XDpr1a was added to an in vitro b-catenin degradation assay after
preincubation with or without CKId followed by anti-Myc immunoprecipitation. b-galactosidase preincubated with or without CKId was used
as a control. Untreated XDpr1a promoted b-catenin degradation,
whereas XDpr1a preincubated with CKId blocked b-catenin degradation. The data shown represent assays repeated six times.
doi:10.1371/journal.pone.0005522.g005

Discussion
XDpr1a is a member of a conserved family of novel Dsh
binding proteins. XDpr1a’s PDZ-B domain interacts with XDsh’s
PDZ domain [18]. Here, we show that XDsh mediates the
phosphorylation of XDpr1a by CKId. In addition, we found that
an intact PDZ-B domain in XDpr1a, as well as an intact PDZ-B
binding domain in XDsh, is required for XDsh-dependent
phosphorylation of XDpr1a by CKId. This suggests that XDpr1a
and CKId/e do not interact directly and/or robustly with one
another, and that XDsh is required to link XDpr1a and CKId/e.
Epigenetic regulation of Dpr expression is associated with
tumorigenesis. Human Dpr1/DACT1 is often downregulated by
allelic loss or promoter methylation in hepatocellular carcinomas
[27,28]. There is reduced DACT3 expression in human colon
tumors due to histone modifications, resulting in increased Wnt
signaling activity; this suppression of DACT3 expression is relieved
in colon cancer cell lines by treatment with histone methylation
and deacetylase inhibitors [28,29]. In addition, Dpr is upregulated
by the treatment of breast cancer patients with DNA methylation
and histone deacetylase inhibitors [28,29]. Each of these results
suggests that the dominant function of Dpr with regard to tumor
formation is inhibition of Wnt signaling, and that the loss of this
function is associated with tumorigenesis. Our data show that
XDpr1a is phosphorylated by CKId/e, and that this phosphorylation reduces XDpr1a’s interaction with XDsh. Frizzled-1
overexpression, which activates Wnt signaling, results in disparate
localizations of XDsh and XDpr1a, causing the membrane
localization of XDsh but not XDpr1a [18]. CKId’s ability to
reduce XDsh/XDpr1a binding may play a part in Wnt’s
localization of XDsh and XDpr1a to disparate locations.
Intriguingly, we found that XDpr1a promotes b-catenin degradation when unphosphorylated but blocks b-catenin degradation
when phosphorylated by CKId. Overall, our data suggest that
XDpr1as acts as a molecular switch in Wnt signaling. In the
absence of CKId/e activity, XDpr1a is bound to XDsh and
inhibits Wnt signaling, whereas XDpr1a promotes Wnt signaling
when phosphorylated by CKId/e.
Cong et al proposed that the N-terminal region of Dsh,
containing the DIX domain, is required for its canonical Wnt
signaling activity, and that Dsh’s C-terminal region, containing the
PDZ and DEP domains, structurally blocks this function [30]. In
addition, they suggest that this inhibition is relieved by the
phosphorylation of Dsh by CKIe. Our data suggest that Dpr is a
missing link in the inhibition of Dsh function. We propose that
Dpr inhibits Dsh’s function in canonical Wnt signaling by binding
to Dsh’s PDZ domain, and preventing Dsh’s DIX domain from
PLoS ONE | www.plosone.org

activating Wnt signaling. Further, the phosphorylation of XDpr1a
and XDsh by CKId/e relieves this suppression by phosphorylating
both XDpr1a and XDsh and reducing their interaction.
We propose a model for the regulation of Wnt signaling based
on our data, as well as that from several other labs, in which the
phosphorylation state of Dpr acts as a molecular switch to
determine whether Dpr inhibits or activates Wnt signaling. In the
absence of Wnt, unphosphorylated XDpr1a binds to XDsh in the
b-catenin degradation complex and inhibits Wnt signaling. When
Wnt binds to LRP5/6 and fz coreceptors, the b-catenin
degradation complex moves to the membrane through the
interactions of axin with LRP5/6 and Dsh with fz, [2–6]. This
results in CKId/e-mediated phosphorylation of XDsh, XDpr1a,
and other substrates [24]. The b-catenin degradation complex
then partially dissociates, with b-catenin, APC, and XDsh
remaining at the membrane, while PP2A A and C subunits [8]
and XDpr1a are released from the complex. Phosphorylated
XDpr1a then associates with distinct Wnt pathway binding
partners and activates Wnt signaling. Future experimentation will
determine if the phosphorylation state of XDpr1a affects its
association with other known Wnt pathway protein partners. Our
data suggest that LEF1, HDAC, and b-catenin may differentially
associate with unphosphorylated XDpr1a, while Tcf3 may
differentially associate with CKId/e-phosphorylated XDpr1a.

Materials and Methods
In vitro phosphorylation assay
In vitro transcription and translation was performed with
[35S]methionine (Amersham Biosciences Corp., Piscataway, NJ)
using TNT SP6 Quick Coupled Transcription/Translation
System (Promega, Madison, WI) according to the manufacturer’s
instructions. Unlabeled proteins were prepared with TNT SP6
Quick Coupled Transcription/Translation System using cold
methionine. XDpr1a and XDsh TNT reactions were mixed at a
ratio of 1:1 in a reaction also containing 5 mM MgCl2 and
0.5 mM ATP. Rat CKId lacking its autoinhibitory C-terminal
domain (New England Biolabs, Ipswich, MA) or GSK3b (New
5
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England Biolabs, Ipswich, MA), was added to a final concentration
of 1.1 mM, and the phosphorylation reactions were carried out for
1.5 hours at 30uC. Where specified, [35S]methionine-labeled
luciferase was added to the phosphorylation reactions, and bands
were quantitated after denaturing SDS-PAGE using a Molecular
Dynamics PhosphorImager and ImageQuant software. Where
specified, [c-33P]ATP was added to the CKId reactions followed
by a 1.5 hour incubation at 30uC.

2 hours. Immunoprecipitates were washed three times with
50 mM Tris-HCl pH 7.4, 137 mM NaCl, followed by denaturing
SDS-PAGE, visualization by autoradiography, and quantitation
using a Molecular Dynamics PhosphorImager and ImageQuant
software. The charted coimmunoprecipitation data is the percentage of XDsh in the immunoprecipitate (versus total input), divided
by the percentage of XDpr1a in the immunoprecipitate (versus
total input), normalized to 1.0 in the absence of CKId (n = 4 trials).

Cell culture

b-catenin degradation assays

For in vivo labeling, HEK293 cells were transfected with
Flag:XDpr1a, HA:XDsh, and CKIe, or Flag:XDpr1a with empty
vector, using Lipofectamine Plus (Invitrogen, Carlsbad, CA) and
metabolically labeled with [32P]orthophosphoric acid (PerkinElmer, Boston, MA). Cells were homogenized in lysis buffer (50 mM
Tris 7.5, 150 mM NaCl, 1% Triton X-100, 100 mM NaF,
0.5 mM Na3VO4, 10 mM b-glycerol phosphate), followed by
anti-Flag immunoprecipitations, SDS-PAGE, and visualization
using a Molecular Dynamics PhosphorImager. XDpr1a’s molecular weight was determined in the absence or presence of CKIe
and XDsh from three experimental trials using GelScape (www.
gelscape.ualberta.ca:8080/htm/index.html).

Xenopus egg extracts were prepared, RNA was synthesized and
translated, and degradation assays were carried out as described
previously with minor modifications [8,25,26]. Myc:XDpr1a or bgalactosidase was preincubated with or without CKId following its
translation in egg extracts. Anti-Myc immunoprecipitates were
washed prior to being added to fresh egg extract for the
degradation assay, which contained 40 mM IC261 to inhibit any
potential carryover CKId activity. [35S]b-catenin was synthesized
using TNT T7 coupled wheat germ extract system (Promega,
Madison, WI). Degradation assays were performed six times, with
aliquots removed at 0, 0.5, 1.0, and 2.0 hours. Aliquots were
resolved using SDS-PAGE, imaged using a Molecular Dynamics
PhosphorImager, and quantitated using ImageQuant software.

In vitro coimmunoprecipitations
[c-33P]ATP-labeled Myc:XDpr1a was immunoprecipitated in
the presence of anti-Myc beads for 2 hours at room temperature.
Immunoprecipitates were washed three times with 50 mM TrisHCl pH 7.4, 137 mM NaCl, followed by SDS-PAGE and
visualization by autoradiography. XDpr1a’s molecular weight
was determined in the absence or presence of CKId and XDsh
from three experimental trials using GelScape (www.gelscape.
ualberta.ca:8080/htm/index.html).
[35S]methionine-labeled
Myc:XDpr1a was immunoprecipitated in the presence of antiMyc antibodies and protein A agarose at room temperature for
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